Supply Chain Intelligence

Petros Pharmaceuticals, Inc. Supply Chain

PTPI supply chain intelligence for Petros Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

PTPI ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

1Suppliers
3Customers
2Debt Items
20Related Chains

Petros Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
VIVUS-INC VIVUS-INC 92% Metuchen granted to Vivus a continuing security interest in all of its Stendra® API and products and its rights under the License Agreement

Petros Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
TIMM-MEDICAL-TECHNOLOGIES-INC TIMM-MEDICAL-TECHNOLOGIES-INC 90% Petros also historically marketed its own line of ED products in the form of vacuum erection device products through its previous subsidiaries, Timm Medical and PTV
VIVUS-INC VIVUS-INC 90% Metuchen agreed to transfer all completed inventory of Stendra® and all substantially manufactured inventory of Stendra® on hand to Vivus at Metuchen’s sole expense
METUCHEN METUCHEN 85% Petros has an established industry-wide network of prospective companies that may license our technology, if it is successfully developed, which the Company expects will serve as its primary target c…

Petros Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PTPI-DEBT-11947 Warrants outstanding: 0.27 90% xbrl warrant detail from xbrl 2026-03-31.
PTPI-DEBT-11948 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Petros Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Petros Pharmaceuticals, Inc..

Petros Pharmaceuticals, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Petros Pharmaceuticals, Inc..

Petros Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
GRDX GridAI Technologies Corp. 100.00 2
View PTPI supply chain intel →

Explore the full interactive supply chain map for Petros Pharmaceuticals, Inc..

Open PTPI supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map